How Recursion is leading a new era of AI-driven drug discovery AI drug discovery is not a new phenomenon – but it is evolving at an almost dizzying pace. Recursion is one of the earliest innovators in ...
On Tuesday, the AI company Recursive Superintelligence announced a $410 million compute deal with Amazon Web Services. The company, which emerged from stealth in May with $650 million in funding, is ...
Even if Rabindranath Tagore occupies what might appear to be a singular position in world literature today, this centrality was neither inevitable nor uncontested. Contemporaries, including ...
Ex-Google engineer's conviction for stealing AI secrets partially overturned A federal judge on Thursday tossed part of the conviction of former Google software engineer Linwei Ding, who was found ...
Structure-based drug design is the design and optimization of a chemical structure with the goal of identifying a compound suitable for clinical testing — a drug candidate. It is based on knowledge of ...
Toroidal magnetic states are difficult to prepare and detect in molecules. The authors show that near-infrared light can drive finite-temperature toroidal polarization in an Fe 10 Dy 10 molecular ring ...
View the basic RXRX option chain and compare options of Recursion Pharmaceuticals, Inc. on Yahoo Finance.
Access detailed historical stock prices, including daily closing prices, for RXRX. Analyze past performance trends, track price movements, and explore historical data to inform your investment ...
Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company that combines automation, artificial intelligence, machine learning, and in vivo validation capabilities to discover novel ...
Recursion Pharmaceuticals insiders completed 6 transactions totaling $589,430.56. Activity included 2 tax-related stock dispositions, 2 open market sales, and 2 stock awards (non-cash). View more ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results